PECAM1 and neoplasm: CREKA-IO-NP binding in tumours correlates with the location of CD31-positive endothelia (Figure 5A), whereas CSG-IO-NP binding correlates mainly with tumour ECM detected with collagen I, laminin and nidogen-1 staining (Figure 5B).